Arysta and Plant Health Care Strike License Deal
29 April 2013 
Arysta LifeScience and Plant Health Care signed a product development and license agreement for use of Plant Health Care’s proprietary harpin alpha beta technology, or “Harp-N-Tek.” Sales of the product are anticipated in the United States following registration in time for the 2014 season.
According to U.S.-based Plant Health Care, Harp-N-Tek is a technology platform for the production of harpin proteins that are formulated into pathogen-free products. When Harp-N-Tek seed treatments or foliar plant health regulators are applied, the plants turn on stress-defense and growth systems. According to Plant Health Care, the result is improved crop vigor, stamina, nutrient uptake and reproductive growth. In addition, this technology is also said to reduce nematode egg and juvenile populations among roots.
Although commercial terms of the agreement were not disclosed, Arysta LifeScience says it will develop and commercialize harpin alpha beta in several crops and markets in combination with a number of its branded products.
Paul Schmidt, CEO of Plant Health Care, said, “We are delighted to enter into this relationship with Arysta LifeScience, which promises a number of new products that will use Harpin alpha beta technology to offer improved plant health benefits and superior disease control.”
Wayne Hewett, President and CEO of Arysta LifeScience, said, “The technology has been validated in the United States corn and soybean market, and Arysta LifeScience is focused on launching new products in the United States market in 2014 as well as developing the concept in a number of crops and countries.”
Get The Newsletter Today!
